Comparison

Purfalcamine European Partner

Item no. TMO-T38269-100mg
Manufacturer TargetMol
CASRN 1038620-68-6
Amount 100mg
Category
Type Inhibitor
Specific against other
Purity 0,98
Smiles N[C@H]1CC[C@@H](CC1)Nc1nc(Nc2ccc(cc2)C(=O)N2CCCCC2)c2ncn(-c3cccc(F)c3)c2n1 |wU:4.7,wD:1.0,(4,8.47,;4,6.93,;2.67,6.16,;2.67,4.62,;4,3.85,;5.33,4.62,;5.33,6.16,;4,2.31,;2.67,1.54,;2.67,,;1.33,-.77,;1.33,-2.31,;,-3.08,;,-4.62,;-1.33,-5.39,;-2.67,-4.62,;-2.67,-3.08,;-1.33,-2.31,;-4,-5.39,;-4,-6.93,;-5.33,-4.62,;-6.67,-5.39,;-8,-4.62,;-8,-3.08,;-6.67,-2.31,;-5.33,-3.08,;;-1.46,-.48,;-2.37,.77,;-1.46,2.02,;-1.94,3.48,;-.91,4.63,;-1.39,6.09,;-2.89,6.41,;-3.92,5.27,;-5.43,5.59,;-3.45,3.8,;,1.54,;1.33,2.31,)|
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Short Description
Purfalcamine is an orally active, selective Plasmodium falciparum calcium-dependent protein kinase 1 (PfCDPK1) inhibitor with an IC50 of 17 nM and an EC50 of 230 nM. Purfalcamine has antimalarial activity and causes malaria parasites developmental arrest at the schizont stage[1][2].
Shipping
cool pack
Storage
-20°
Molecular Weight
528, 636

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close